The article, “Hazmat suit maker’s stock up 50% on Ebola fears” by Paul R. La Monica describes the effect of the Ebola virus on the demand for medication. The article states that with the cases of the ebola virus around the world fear of contracting the virus has increased dramatically, and so has the demand for preventative medications. The high demand, however, for these medications is much greater than companies are currently able to produce. In short, the companies producing the medication lack the capacity to produce the amount of medication demanded.
In short, the widespread fear of the Ebola virus has caused such a great demand for preventative medication that companies are unable to meet the high demand. What can companies do to meet the demand?